GENE ONLINE|News &
Opinion
Blog

Alzheimer's Disease
Trials & Approvals Alzheimer's Disease
Though Alzheimer’s Treatment Fails Presenting Primary Endpoints, TauRx is Still Seeking Approval
2022-10-06
Trials & Approvals Biogen
Biogen Concludes $900 Million Settlement Before Posting Positive Data From Alzheimer’s Trial
2022-09-28
Deals Alzheimer's Disease
Merck Dangles $1.1 Billion For Cerevance To Discover New Targets For Alzheimer’s
2022-08-10
Special Alzheimer's Disease
Billions of Research Dollars May Have Been Wasted Due to Fraudulent Alzheimer’s Study
2022-07-26
Trials & Approvals Alzheimer's Disease
Roche Bags Fast Track Label for New Alzheimer’s Diagnostic
2022-07-21
Technology Dementia
Alleviating Depression and Dementia with Transcorneal Electrical Stimulation
2022-07-11
R&D Alzheimer's Disease
Are Memory Loss in Alzheimer’s Disease Related to Changes in Blood Vessels in the Brain?
2022-07-07
Funding Neurodegenerative Disease
NRG Therapeutics Wins £2.68M to Treat Chronic Neurodegenerative Disorders
2022-05-31
Regulatory Alzheimer's Drug
Eisai to File Another Biogen-Partnered Alzheimer’s Drug After Confidence Hit
2022-05-10
Trials & Approvals Alzheimer's Disease
FDA Greenlights First In-Vitro Alzheimer’s Diagnostic
2022-05-05
Trials & Approvals Biogen
Biogen Halts Aduhelm’s Second EU Marketing Application
2022-04-25
Innovation Brain Atrophy
The Brain Size Changes with Age: A First Worldwide Brain Study
2022-04-20
Regulatory Alzheimer's Drug
CMS’s New Ruling on Biogen’s Aduhelm Restriction Coverage
2022-04-13
Innovation Alzheimer's Disease
MGC Pharmaceuticals Enters Partnership with Sciensus Rare for Distribution of Cannabinoids to Treat Refractory Epilepsy, Dementia and Alzheimer’s in the EU and UK
2022-04-05
Deals South Korea
Alliance Formed: SV Investment and Orange Grove Bio Jointly Source and Develop Novel Medications in the U.S. and Korea
2022-03-16
1 2 3 4 5
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top